Aristotle Capital Boston, LLC Charles River Laboratories International, Inc. Transaction History
Aristotle Capital Boston, LLC
- $2.63 Billion
- Q4 2024
A detailed history of Aristotle Capital Boston, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Aristotle Capital Boston, LLC holds 130,161 shares of CRL stock, worth $19.6 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
130,161
Previous 144,711
10.05%
Holding current value
$19.6 Million
Previous $28.5 Million
15.71%
% of portfolio
0.91%
Previous 0.97%
Shares
34 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
50MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$927 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$766 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$328 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$272 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$272 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.66B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...